Intravascularly-administrable, magnetically-localizable biodegradable carrier

Claim 2

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.5 microns and said magnetic particles having an average size of not over 1,000 Angstroms, said microspheres containing from 5 to 350 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 90% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeter internal diameter but not over 10% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet with its poles equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for at least 1.0 centimeter in the direction of flow.

Claim 3

The carrier of claim 1 in which said magnetic particles are concentrated in the peripheral portions of said microspheres.

Claim 4

The carrier of claim 1 in which said microspheres contain from 10 to 150 parts by weight of said magnetic material per 100 parts of said amino acid polymer.

Claim 5

The carrier of claim 3 in which said magnetic material is Fe 3 O 4 and said amino acid polymer is albumin.

Claim 6

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeters internal diameter but not over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied with a bipolar magnet with its poles equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for at least 1.0 centimeter in the direction of flow.

Claim 7

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeters internal diameter but not over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied with a bipolar magnet with its poles equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for at least 1.0 centimeter in the direction of flow.

Claim 8

The carrier of claim 5 in which said magnetic particles are concentrated in the peripheral portions of said microspheres.

Claim 9

The carrier of claim 5 in which said magnetic material is Fe 3 O 4 and said amino acid polymer is albumin.

Claim 10

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from albumin with particles of Fe 3 O 4 embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said Fe 3 O 4 particles per 100 parts of said albumin, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeters internal diameter but not over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied with a bipolar magnet with its poles equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for at least 1.0 centimeter in the direction of flow.

Claim 11

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from albumin with particles of Fe 3 O 4 embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said Fe 3 O 4 particles per 100 parts of said albumin, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeters internal diameter but not over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied with a bipolar magnet with its poles equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for at least 1.0 centimeter in the direction of flow.

Claim 12

The carrier of claim 8 in which said Fe 3 O 4 particles are concentrated in the peripheral portions of said microspheres.

Claim 13

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.5 microns and said magnetic particles having an average size of not over 1,000 Angstroms, said microspheres containing from 5 to 350 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 90% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeter internal diameter but not over 10% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet having pole faces of 12.7 millimeters in width with said pole faces equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for substantially 12.7 millimeters in the direction of flow.

Claim 14

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.5 microns and said magnetic particles having an average size of not over 1,000 Angstroms, said microspheres containing from 5 to 350 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 90% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeter internal diameter but not over 10% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet having pole faces of 12.7 millimeters in width with said pole faces equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for substantially 12.7 millimeters in the direction of flow.

Claim 15

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeters internal diameter but not over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet having pole faces of 1.27 centimeters in width with said pole faces equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for substantially 1.27 centimeters in the direction of flow.

Claim 16

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from an amino acid polymer matrix with magnetic particles embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said magnetic particles per 100 parts of said amino acid polymer, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second through a conduit of 0.168 centimeters internal diameter but not over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet having pole faces of 1.27 centimeters in width with said pole faces equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for substantially 1.27 centimeters in the direction of flow.

Claim 17

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from albumin with particles of Fe 3 O 4 embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said Fe 3 O 4 particles per 100 parts of said albumin, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet having pole faces of 1.27 centimeters in width with said pole faces equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for substantially 1.27 centimeters in the direction of flow.

Claim 18

An intravascularly-administrable, magnetically-localizable biodegradable carrier, comprising microspheres formed from albumin with particles of Fe 3 O 4 embedded therein, said microspheres having an average size of less than 1.2 microns and said magnetic particles having an average size of not over 300 Angstroms, said microspheres containing from 10 to 150 parts by weight of said Fe 3 O 4 particles per 100 parts of said albumin, at least 95% of said microspheres being immobilized by a magnetic induction of 8,000 gauss when an aqueous suspension of said microspheres is pumped at a rate of 0.05 centimeters per second over 5% of said microspheres being immobilized by said magnetic induction when pumped through said conduit at a flow rate of 10 centimeters per second, said magnetic induction being applied by a bipolar magnet having pole faces of 1.27 centimeters in width with said pole faces equidistant from the centerline of said tube, said 8,000 gauss being referenced to a plane intersecting said tube at right angles to the direction of flow and extending for substantially 1.27 centimeters in the direction of flow.